HIV care and treatment
(TheNewYorkTimes) ICAP’s Elaine Abrams Comments on the New Berry-Flavored HIV Medication for Babies
ICAP’s Elaine Abrams, MD, senior research director, was featured in a Nov 30 article in The New York Times, which reported that for the 80,000 children who die of H.I.V. each year, drugs are often bitter or hard to swallow. Dolutegravir will soon come in a tasty...
New Option for HIV Prevention Shows Tremendous Promise in Women, According to Clinical Study Supported by ICAP in Eswatini
A landmark clinical study supported by ICAP has demonstrated that an injectable form of Pre-Exposure Prophylaxis (PrEP) is highly effective in preventing HIV acquisition in women, presenting a welcome new option to help keep women safe from the virus that causes AIDS....
(Columbia Public Health Magazine) ICAP’s Wafaa El-Sadr on Helping Africa Face the Fight Against COVID-19
Wafaa El-Sadr, MD, MPH, MPA, global director of ICAP, was consulted for an Nov 19 article in Columbia Public Health Magazine which reflected on the speed at which experts from all corners of the Mailman School mobilized to respond to COVID-19 as it swept the globe....